Copyright
©The Author(s) 2017.
World J Gastroenterol. Aug 14, 2017; 23(30): 5519-5529
Published online Aug 14, 2017. doi: 10.3748/wjg.v23.i30.5519
Published online Aug 14, 2017. doi: 10.3748/wjg.v23.i30.5519
Figure 2 Immunohistochemical analyses of interleukin-26 in the inflamed mucosa of inflammatory bowel disease patients.
A: Immunostaining for IL-26 in normal mucosa and inflamed mucosa of UC and CD. Pictures are shown from one of four independent samples with similar results. Magnification; upper panel × 200, lower panel × 400; B: Dual-colored immunofluorescence was used to determine the expression of IL-26 (green fluorescence) and CD4, CD56 and CD68 (red fluorescence) in inflamed mucosa of UC patients. Double-positive cells were detected by yellow fluorescence. Pictures are shown from one of four independent samples with similar results. IL: Interleukin; CD: Crohn’s disease; UC: Ulcerative colitis.
- Citation: Fujii M, Nishida A, Imaeda H, Ohno M, Nishino K, Sakai S, Inatomi O, Bamba S, Kawahara M, Shimizu T, Andoh A. Expression of Interleukin-26 is upregulated in inflammatory bowel disease. World J Gastroenterol 2017; 23(30): 5519-5529
- URL: https://www.wjgnet.com/1007-9327/full/v23/i30/5519.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i30.5519